We are live on ! Find out more
CPXX

CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX

Delisted

CPXX was delisted on the 11th of July, 2016.

Back to rankings

119 hedge funds and large institutions have $944M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2016 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more call options, than puts

Call options by funds: $95M | Put options by funds: $21.4M

342% more capital invested

Capital invested by funds: $214M → $944M (+$731M)

258% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 24

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

105% more funds holding

Funds holding: 58 → 119 (+61)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
119
Holders Change
+61
Holders Change %
+105.17%
% of All Funds
3.17%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
86
Increased
21
Reduced
10
Closed
24
Calls
$95M
Puts
$21.4M
Net Calls
+$73.6M
Net Calls Change
+$74.3M

Top Buyers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
+$45M
2
MF
Magnetar Financial
Illinois
+$32.3M
3
AA
AQR Arbitrage
Connecticut
+$22.6M
4
Deutsche Bank
Deutsche Bank
Germany
+$19.9M
5
GCL
Glazer Capital LLC
New York
+$19.6M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$16M
2
RCM
RA Capital Management
Massachusetts
-$15.6M
3
Millennium Management
Millennium Management
New York
-$12.6M
4
EC
EcoR1 Capital
California
-$10.5M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
76
RhumbLine Advisers
Massachusetts
$1.02M +$683K +33,659 New
VKH
77
Virtu KCG Holdings
New York
$815K +$548K +27,004 New
SM
78
Sabby Management
Florida
$800K +$30.4K +1,500 +6%
Citadel Advisors
79
Citadel Advisors
Florida
$776K +$219K +10,781 +72%
O
80
OppenheimerFunds
New York
$775K +$521K +25,674 New
State Board of Administration of Florida Retirement System
81
State Board of Administration of Florida Retirement System
Florida
$775K +$521K +25,685 New
FMA
82
FNY Managed Accounts
New York
$758K +$509K +25,100 New
Capstone Investment Advisors
83
Capstone Investment Advisors
New York
$754K +$507K +25,000 New
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
$729K +$490K +24,149 New
BA
85
BlackRock Advisors
Delaware
$718K +$418K +20,580 +640%
Citigroup
86
Citigroup
New York
$707K +$475K +23,422 +137,776%
Millennium Management
87
Millennium Management
New York
$678K -$12.6M -621,336 -97%
NFA
88
Nationwide Fund Advisors
Ohio
$646K +$435K +21,417 New
Manulife (Manufacturers Life Insurance)
89
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$638K +$429K +21,128 New
CCM
90
Cadence Capital Management
Massachusetts
$623K +$419K +20,630 New
AIG
91
American International Group
New York
$568K +$382K +18,804 New
DCM
92
Dupont Capital Management
Delaware
$504K +$339K +16,700 New
DC
93
Deere & Company
Illinois
$451K -$637K -31,387 -68%
VOYA Investment Management
94
VOYA Investment Management
Georgia
$427K +$287K +14,138 New
BG
95
BlackRock Group
United Kingdom
$409K +$276K +13,579 New
Wells Fargo
96
Wells Fargo
California
$407K +$225K +11,100 +463%
UBS AM
97
UBS AM
Illinois
$398K +$268K +13,200 New
Squarepoint
98
Squarepoint
New York
$380K +$256K +12,600 New
FWM
99
Frontier Wealth Management
Missouri
$377K +$254K +12,500 New
TI
100
Telemetry Investments
New York
$338K +$227K +11,200 New
2 3
4
5 6

CPXX Hedge Fund Activity: Q2 2016 in Review

119 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q2 2016, worth a combined $944M — up 342% from $214M a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CPXX positions and 24 closed out — a net gain of 62 holders — while 21 added to existing stakes and 10 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $45M. The largest seller was Visium Asset Management, exiting entirely with an estimated $16M sold.

  • 119 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q2 2016, up from 58 in Q1 2016.
  • Funds reported $944M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q2 2016, up 342% quarter-over-quarter.
  • 86 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q2 2016 and 24 closed out, a net change of +62 holders.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q2 2016 was Alpine Associates Management, an estimated $45M added.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q2 2016 was Visium Asset Management, an estimated $16M sold.

Based on aggregated 13F filings for Q2 2016.